335 related articles for article (PubMed ID: 8821958)
1. The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast.
Joshi MG; Lee AK; Pedersen CA; Schnitt S; Camus MG; Hughes KS
Mod Pathol; 1996 Jan; 9(1):57-62. PubMed ID: 8821958
[TBL] [Abstract][Full Text] [Related]
2. Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: an immunohistochemical study.
Gottlieb C; Raju U; Greenwald KA
Mod Pathol; 1990 Mar; 3(2):135-40. PubMed ID: 1691493
[TBL] [Abstract][Full Text] [Related]
3. Microglandular adenosis of the breast. An immunohistochemical comparison with tubular carcinoma.
Diaz NM; McDivitt RW; Wick MR
Arch Pathol Lab Med; 1991 Jun; 115(6):578-82. PubMed ID: 1710101
[TBL] [Abstract][Full Text] [Related]
4. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
5. Vimentin expression in benign and malignant lesions in the human mammary gland.
Wada T; Yasutomi M; Hashmura K; Kunikata M; Tanaka T; Mori M
Anticancer Res; 1992; 12(6B):1973-82. PubMed ID: 1284196
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical profile and differential diagnosis of microglandular adenosis.
Tavassoli FA; Bratthauer GL
Mod Pathol; 1993 May; 6(3):318-22. PubMed ID: 8346180
[TBL] [Abstract][Full Text] [Related]
7. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
Raju UB; Lee MW; Zarbo RJ; Crissman JD
Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
[TBL] [Abstract][Full Text] [Related]
8. Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases.
Gusterson BA; Warburton MJ; Mitchell D; Ellison M; Neville AM; Rudland PS
Cancer Res; 1982 Nov; 42(11):4763-70. PubMed ID: 6290045
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical evaluation of the cytoarchitecture of benign and malignant breast lesions.
Soini Y; Miettinen M
APMIS; 1992 Oct; 100(10):901-7. PubMed ID: 1280148
[TBL] [Abstract][Full Text] [Related]
10. The usefulness of p63 as a marker of breast myoepithelial cells.
Batistatou A; Stefanou D; Arkoumani E; Agnantis NJ
In Vivo; 2003; 17(6):573-6. PubMed ID: 14758723
[TBL] [Abstract][Full Text] [Related]
11. [Mammary carcinoma arising in microglandular adenosis: a case report].
Charafe-Jauffret E; Jacquemier J; Lelong B; Meynard P; Mathoulin-Portier MP; Houvenhaegel G; Hassoun J
Ann Pathol; 2001 Oct; 21(5):435-8. PubMed ID: 11852363
[TBL] [Abstract][Full Text] [Related]
12. [Monoclonal antibodies to the proteins of intermediate filaments and of basement membranes in the differential diagnosis of certain forms of human breast tumors].
Gel'shteĭn VI; Chipysheva TA; Ermilova VD; Liubimov AV
Arkh Patol; 1990; 52(9):12-8. PubMed ID: 1702969
[TBL] [Abstract][Full Text] [Related]
13. Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast.
Gould VE; Koukoulis GK; Jansson DS; Nagle RB; Franke WW; Moll R
Am J Pathol; 1990 Nov; 137(5):1143-55. PubMed ID: 1700618
[TBL] [Abstract][Full Text] [Related]
14. [Nodular sclerosing adenosis (adenosis tumor) of the breast. An immunohistologic study particularly in reference to the relationship with radial cicatrix and to the differential diagnosis with tubular carcinoma].
Lanzafame S
Pathologica; 1989; 81(1073):251-66. PubMed ID: 2641538
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical differentiation of atypical hyperplasia vs. carcinoma in situ of the breast.
Masood S; Sim SJ; Lu L
Cancer Detect Prev; 1992; 16(4):225-35. PubMed ID: 1281040
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of keratins 13 and 16 in normal epithelium, benign lesions, and ductal carcinomas of the human breast determined by the monoclonal antibody Ks8.12.
Pellegrino MB; Asch BB; Connolly JL; Asch HL
Cancer Res; 1988 Oct; 48(20):5831-6. PubMed ID: 2458830
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of keratin expression and actin distribution in benign and malignant mammary diseases.
Wada T; Yasutomi M; Yamada K; Hashimura K; Kunikata M; Tanaka T; Huang JW; Mori M
Anticancer Res; 1991; 11(6):1983-93. PubMed ID: 1723260
[TBL] [Abstract][Full Text] [Related]
18. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections.
Moritani S; Kushima R; Sugihara H; Bamba M; Kobayashi TK; Hattori T
Mod Pathol; 2002 Apr; 15(4):397-405. PubMed ID: 11950913
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of S100 protein in benign and malignant conditions of the breast.
Egan MJ; Newman J; Crocker J; Collard M
Arch Pathol Lab Med; 1987 Jan; 111(1):28-31. PubMed ID: 3026280
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast.
Hilson JB; Schnitt SJ; Collins LC
Am J Surg Pathol; 2010 Jun; 34(6):896-900. PubMed ID: 20463570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]